Bring best practices to your patients

Currently, too many biopsies are ordered as soon as a patient’s PSA reaches a level of 4.0.  As a result, 75% of prostateA donut-shaped gland the size and shape of a walnut that surrounds the upper portion of the male urethra. Its main function is to produce part of the fluid that makes up semen. biopsies in the U.S. actually fail to find cancer and many doctors are skeptical of using one PSA test score as a standalone indicator.

But top medical centers use a range of information (including calibrated PSA values) to help determine the cause of an elevated PSA before they order a biopsyA test done to determine the presence of cancer by removing small samples of tissue from an individual’s organ to examine them under a microscope. as a last resort.  Using best practices, you can greatly reduce your risk of encountering false positives and inadvertently discovering indolent cancers, while reducing the risk of recurrence after treatment among your patients.

For a typical man, typical progressing cancerCancer that is progressing at a fast rate and is life-threatening. can be detected earlier by Soar Dynamic Screening when the cancer is smaller (by a factor of up to three compared to using only a PSA threshold of 4.0) and easier to treat. Because Soar looks at the annual rate of change in your patients’ PSA trendThe trend of PSA levels over time. (PSA velocityThe rate at which the PSA level rises.) and other information, using Soar Dynamic Screening can help you detect progressing cancer earlier than using a simple PSA threshold.